Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$69.02 - $93.84 $227,766 - $309,672
-3,300 Reduced 30.84%
7,400 $520,000
Q2 2024

Aug 14, 2024

SELL
$74.43 - $92.22 $3.8 Million - $4.71 Million
-51,100 Reduced 82.69%
10,700 $880,000
Q1 2024

May 15, 2024

BUY
$83.81 - $99.0 $5.18 Million - $6.12 Million
61,800 New
61,800 $5.4 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $12.5 Million - $15.7 Million
-185,000 Reduced 82.22%
40,000 $2.59 Million
Q2 2018

Aug 14, 2018

BUY
$76.01 - $99.03 $17.1 Million - $22.3 Million
225,000 New
225,000 $0

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.